Rely on Worldwide to Bring Your Vasculitis Therapy Trials to Fruition
Every type of vasculitis involves an inflammation of blood vessels. No one knows precisely what causes it, though we do know that certain forms of vasculitis appear only in certain populations. Kawasaki disease affects children, while giant cell arteritis affects people in their 50s and older. Some people experience a single episode of vasculitis; for others, the condition is chronic. For some, the experience is mild; for others, it is fatal.
What is generally agreed upon is that vasculitis has all the characteristics of an autoimmune disorder, and the inflammation in the veins and arteries is a symptom of the immune system attacking itself. If your work in immune-mediated inflammatory disorders (IMID) touches on solutions for vasculitis, it could benefit many people suffering from vasculitis – but only if you can bring it out of the lab and into the clinic.
To do that, your therapy must pass through the rigors of a clinical trial, and that’s where Worldwide Clinical Trials can help. Worldwide has more than 30 years of experience in IMID research, including many years of research supporting therapies specifically targeted at rare and orphan diseases. Worldwide is an internationally acclaimed expert in clinical trial management, offering full-service support for Phase I-Phase IV clinical trials, as well as real-world evidence studies that can help you understand the effects of your work over both the short and long term.
When you’re ready to bring your work to the next stage, contact Worldwide.